• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

淋巴结比率作为 III 期结肠癌的质量和预后指标。

Lymph node ratio as a quality and prognostic indicator in stage III colon cancer.

机构信息

*Department of Surgery, University of California, Davis, CA, USA.

出版信息

Ann Surg. 2011 Jan;253(1):82-7. doi: 10.1097/SLA.0b013e3181ffa780.

DOI:10.1097/SLA.0b013e3181ffa780
PMID:21135690
Abstract

BACKGROUND

The presence and number of nodal metastasis significantly impact colon cancer prognosis. Similarly, the number of resected/evaluated nodes impacts staging accuracy. This ratio of metastatic to examined nodes or lymph node ratio (LNR) may have independent prognostic value in colon carcinoma.

PURPOSE

: To evaluate the impact of LNR on overall survival in colon cancer patients with fewer than 12 or 12 examined nodes or more.

METHODS

Patients (n = 36,712) with node-positive nonmetastatic colon cancer diagnosed between 1992 and 2004 were identified from the Surveillance, Epidemiology, and End Results database and stratified according to LNR and number of nodes examined. Survival was estimated by Kaplan-Meier method, and differences analyzed by log-rank test. A Cox proportional hazards model was used for multivariate analysis.

RESULTS

Patients with fewer than 12 nodes were older and male and had lower primary tumor stage, grade, and N stage (P < 0.01). Survival appeared greater with 12 total nodes examined or more (median 53 vs. 66 months, P < 0.001). Within each LNR stratum, survival with 12 nodes or more was improved for those with less than 10% of nodes positive for cancer, but was worse with higher LNRs (P < 0.01). Lymph node ratio was significantly associated with survival independent of total nodes (HR 1.24-5.12, P < 0.001). Other significant factors included age, race, tumor grade, stage, location, and N stage.

CONCLUSION

Metastatic LNR independently estimates survival in Stage III colon cancer, irrespective of number of nodes examined. However, statistically significant differences in each LNR stratum between those with resection of fewer than 12 or 12 nodes or more would indicate that a 12-node minimum may still be necessary for accurate staging.

摘要

背景

淋巴结转移的存在和数量对结肠癌的预后有重要影响。同样,切除/评估的淋巴结数量也会影响分期的准确性。淋巴结转移与检查淋巴结的比例或淋巴结比率(LNR)在结肠癌中可能具有独立的预后价值。

目的

评估 LNR 对淋巴结阳性非转移性结肠癌患者中淋巴结转移数量较少(<12 个或 12 个)或较多(≥12 个)的总体生存的影响。

方法

从监测、流行病学和最终结果数据库中确定了 1992 年至 2004 年期间诊断为淋巴结阳性非转移性结肠癌的患者(n=36712),并根据 LNR 和检查的淋巴结数量进行分层。通过 Kaplan-Meier 法估计生存情况,通过对数秩检验分析差异。采用 Cox 比例风险模型进行多因素分析。

结果

淋巴结转移数量<12 个的患者年龄较大,男性比例较高,原发肿瘤分期、分级和 N 分期较低(P<0.01)。检查 12 个或更多淋巴结的患者的生存时间更长(中位数 53 个月与 66 个月,P<0.001)。在每个 LNR 分层内,LNR<10%的患者检查 12 个或更多淋巴结时生存情况得到改善,但 LNR 较高的患者生存情况更差(P<0.01)。LNR 与总淋巴结数独立相关(HR 1.24-5.12,P<0.001)。其他重要因素包括年龄、种族、肿瘤分级、分期、位置和 N 分期。

结论

转移性 LNR 独立于检查的淋巴结数量,估计 III 期结肠癌的生存情况。然而,在 LNR 各分层中,那些切除<12 个或 12 个淋巴结或更多的患者之间存在统计学显著差异,这表明为了准确分期,仍可能需要 12 个淋巴结的最低数量。

相似文献

1
Lymph node ratio as a quality and prognostic indicator in stage III colon cancer.淋巴结比率作为 III 期结肠癌的质量和预后指标。
Ann Surg. 2011 Jan;253(1):82-7. doi: 10.1097/SLA.0b013e3181ffa780.
2
Lymph node ratio as prognosis factor for colon cancer treated by colorectal surgeons.淋巴结比率作为结直肠外科医生治疗结肠癌的预后因素。
Dis Colon Rectum. 2009 Jul;52(7):1244-50. doi: 10.1007/DCR.0b013e3181a65f0b.
3
Nodal status, number of lymph nodes examined, and lymph node ratio: what defines prognosis after resection of colon adenocarcinoma?淋巴结状态、检查的淋巴结数量和淋巴结比率:切除结肠癌后,哪些因素决定预后?
J Am Coll Surg. 2013 Dec;217(6):1090-100. doi: 10.1016/j.jamcollsurg.2013.07.404. Epub 2013 Sep 14.
4
Lymph node ratio as determined by the 7th edition of the American Joint Committee on Cancer staging system predicts survival in stage III colon cancer.第 7 版美国癌症联合委员会分期系统确定的淋巴结比率可预测 III 期结肠癌的生存情况。
J Surg Oncol. 2011 Apr;103(5):406-10. doi: 10.1002/jso.21830. Epub 2010 Dec 22.
5
Survival in stage III colon cancer is independent of the total number of lymph nodes retrieved.III期结肠癌的生存率与所获取淋巴结的总数无关。
J Am Coll Surg. 2009 Jan;208(1):42-7. doi: 10.1016/j.jamcollsurg.2008.10.013.
6
The metastatic lymph node ratio predicts survival in colon cancer.转移性淋巴结比率可预测结肠癌患者的生存率。
Am J Surg. 2007 Dec;194(6):827-31; discussion 831-2. doi: 10.1016/j.amjsurg.2007.08.030.
7
Prognostic significance of metastatic lymph node ratio in node-positive colon carcinoma.淋巴结阳性结肠癌中转移淋巴结比率的预后意义
Ann Surg Oncol. 2007 May;14(5):1712-7. doi: 10.1245/s10434-006-9322-3. Epub 2007 Jan 26.
8
Nodal stage of stage III colon cancer: the impact of metastatic lymph node ratio.III期结肠癌的结节分期:转移淋巴结比率的影响
J Surg Oncol. 2009 Sep 1;100(3):240-3. doi: 10.1002/jso.21273.
9
Prognostic relevance of lymph node ratio and number of resected nodes after curative resection of ampulla of Vater carcinoma.壶腹癌根治性切除术后淋巴结比率及切除淋巴结数量的预后相关性
Ann Surg Oncol. 2008 Nov;15(11):3178-86. doi: 10.1245/s10434-008-0099-4. Epub 2008 Aug 20.
10
Adequacy and importance of lymph node evaluation for colon cancer in the elderly.老年结肠癌患者淋巴结评估的充分性及重要性
J Am Coll Surg. 2008 Feb;206(2):247-54. doi: 10.1016/j.jamcollsurg.2007.07.044. Epub 2007 Oct 29.

引用本文的文献

1
Prognostic value of metastatic lymph node ratio and its effect on disease-free survival in colon cancer.转移性淋巴结比率在结肠癌中的预后价值及其对无病生存期的影响
Front Oncol. 2025 Aug 27;15:1624798. doi: 10.3389/fonc.2025.1624798. eCollection 2025.
2
The clinical significance of the lymph node ratio as a recurrence indicator in ampullary cancer after curative pancreaticoduodenectomy.淋巴结比率作为胰十二指肠切除术后壶腹癌复发指标的临床意义。
Langenbecks Arch Surg. 2024 Oct 8;409(1):302. doi: 10.1007/s00423-024-03481-y.
3
Impact of Metastatic Lymph Node Ratio on Survival and Prognosis in Rectal Carcinoma: A Retrospective Cohort Study.
转移性淋巴结比率对直肠癌生存及预后的影响:一项回顾性队列研究
Cureus. 2024 Sep 5;16(9):e68734. doi: 10.7759/cureus.68734. eCollection 2024 Sep.
4
What is your count? An observational study of lymph node counting in 2,028 colorectal cancer resections.你的计数是多少?一项观察性研究,对 2028 例结直肠癌切除术后的淋巴结计数进行了研究。
PLoS One. 2024 Feb 8;19(2):e0295209. doi: 10.1371/journal.pone.0295209. eCollection 2024.
5
Prognostic Value of Metastatic Lymph Node Ratio and Identification of Factors Influencing the Lymph Node Yield in Patients Undergoing Curative Colon Cancer Resection.根治性结肠癌切除患者中转移淋巴结比率的预后价值及影响淋巴结获取量的因素分析
Cancers (Basel). 2024 Jan 2;16(1):218. doi: 10.3390/cancers16010218.
6
A retrospective study analyzing if lymph node ratio carbon nanoparticles predict stage III rectal cancer recurrence.一项回顾性研究,分析淋巴结碳纳米颗粒比率是否可预测III期直肠癌复发。
Front Oncol. 2023 Oct 30;13:1238300. doi: 10.3389/fonc.2023.1238300. eCollection 2023.
7
Assessing the role of central lymph node ratio in predicting recurrence in N1a low-to-intermediate risk papillary thyroid carcinoma.评估中央淋巴结比值在预测 N1a 低-中危甲状腺乳头状癌复发中的作用。
Front Endocrinol (Lausanne). 2023 Sep 14;14:1158826. doi: 10.3389/fendo.2023.1158826. eCollection 2023.
8
Screening and validation of a novel T stage-lymph node ratio classification for operable colon cancer.可切除结肠癌新型T分期-淋巴结比率分类的筛查与验证
Ann Transl Med. 2021 Oct;9(20):1513. doi: 10.21037/atm-21-3170.
9
Outcomes of Non-metastatic Colon Cancer: A Single-Center Experience.非转移性结肠癌的治疗结果:单中心经验
Cureus. 2021 Sep 1;13(9):e17657. doi: 10.7759/cureus.17657. eCollection 2021 Sep.
10
Prognostic nomogram to predict the overall survival of patients with early-onset colorectal cancer: a population-based analysis.基于人群分析的早发性结直肠癌患者总生存预后列线图预测模型。
Int J Colorectal Dis. 2021 Sep;36(9):1981-1993. doi: 10.1007/s00384-021-03992-w. Epub 2021 Jul 29.